T654-0317 Screening compound: N~1~-(2,5-dimethylphenyl)-2-(5-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-3-yl)-1-indolinecarboxamide

T654-0317 Screening compound: N~1~-(2,5-dimethylphenyl)-2-(5-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-3-yl)-1-indolinecarboxamide
T654-0317 Screening compound: N~1~-(2,5-dimethylphenyl)-2-(5-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-3-yl)-1-indolinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T654-0317
N~1~-(2,5-dimethylphenyl)-2-(5-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-3-yl)-1-indolinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T654-0317

Molecular Formula

C24H26N4O3 (C24 H26 N4 O3)

Compound Name

N~1~-(2,5-dimethylphenyl)-2-(5-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-3-yl)-1-indolinecarboxamide

IUPAC name

N-(25-dimethylphenyl)-2-[5-(oxan-4-yl)-124-oxadiazol-3-yl]-23-dihydro-1H-indole-1-carboxamide

SMILES

Cc1cc(NC(N(C(C2)c3noc(C4CCOCC4)n3)c3c2cccc3)=O)c(C)cc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

418.5

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.971

Distribution Coefficient, logD

4.971

Water Solubility, LogSw

-4.60

Polar Surface Area

62.895

Acid Dissociation Constant (pKa)

13.30

Base Dissociation Constant (pKb)

-0.59

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

37.50

T654-0317 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Indole Derivatives (10091 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with T654-0317 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T654-0317?
Check Price and Availability of T654-0317, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T654-0317 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T654-0317
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T654-0317
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T654-0317 available by request